CT Financial Advisors’s Pfizer PFE Stock Holding History

CT Financial Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$681K	Buy	20,969 +8	+0%	+$252	0.42%	62
2016 Q4	$646K	Buy	20,961 +7	+0%	+$214	0.41%	64
2016 Q3	$673K	Sell	20,954 -383	-2%	-$12.8K	0.41%	60
2016 Q2	$713K	Sell	21,337 -120	-0.6%	-$3.83K	0.44%	54
2016 Q1	$603K	Sell	21,457 -1,636	-7%	-$46.7K	0.34%	75
2015 Q4	$707K	Sell	23,093 -731	-3%	-$23K	0.41%	60
2015 Q3	$710K	Sell	23,824 -262	-1%	-$8.4K	0.45%	59
2015 Q2	$766K	Sell	24,086 -995	-4%	-$32.4K	0.43%	62
2015 Q1	$828K	Sell	25,081 -310	-1%	-$9.86K	0.46%	59
2014 Q4	$750K	Buy	+25,391	New	+$728K	0.57%	43
2014 Q1	$828K	Buy	+25,081	New	+$748K	0.46%	59

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CT Financial Advisors's PFE Position: Q1 2017 in Review

CT Financial Advisors increased its Pfizer (PFE) stake by 0.04% in Q1 2017, buying an estimated $252 and bringing the position to 20,969 shares worth $681K. The position accounts for 0.42% of the portfolio, ranked #62.

CT Financial Advisors first reported a position in PFE in Q1 2014 and has held it in 11 quarters since. The position peaked at $828K in Q1 2015. 2,074 funds tracked by Wall St. Rank hold PFE as of Q1 2017.

CT Financial Advisors held 20,969 shares of Pfizer worth $681K as of Q1 2017.
CT Financial Advisors bought 8 Pfizer shares in Q1 2017, an estimated $252.
Pfizer made up 0.42% of CT Financial Advisors's portfolio in Q1 2017, its #62 holding.
CT Financial Advisors first reported a position in Pfizer in Q1 2014 and has held it in 11 quarters since.
CT Financial Advisors's Pfizer position peaked at $828K in Q1 2015.
2,074 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.

Based on CT Financial Advisors's 13F filing for Q1 2017, filed 7 Apr 2017.